Immunosuppressive acidic protein (IAP) level used to monitor adjuvant arthritis in rats

Citation
H. Yanaguimoto et al., Immunosuppressive acidic protein (IAP) level used to monitor adjuvant arthritis in rats, RES COM M P, 108(1-2), 2000, pp. 57-61
Citations number
12
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
ISSN journal
10780297 → ACNP
Volume
108
Issue
1-2
Year of publication
2000
Pages
57 - 61
Database
ISI
SICI code
1078-0297(200007/08)108:1-2<57:IAP(LU>2.0.ZU;2-H
Abstract
To determine if immunosuppressive acidic protein (IAP) responds to the degr ee of inflammation in adjuvant arthritis in rats (AA), we measured the seru m IAP level of the rats by using the single immunodiffusion method, and the level of concanavalin A (Con A) binding protein by using nepherometry. Pha rmacologic treatment with 0.3mg/kg of methotrexate (MTX) was done from day 5 to 14 postimmunization in rats with AA. The measured serum IAP level on d ay 21 indicated the most severe inflamed phase. IAP levels reflected the de gree of primary and secondary inflammatory phases in AA, whereas ConA bindi ng protein (CBP) levels did not. Our results suggest that IAP can be used t o monitor the symptoms of inflammation and the efficacy of anti-inflammator y drugs.